nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A cost-effectiveness analysis of South Africa’s seasonal influenza vaccination programme
|
Edoka, Ijeoma |
|
|
39 |
2 |
p. 412-422 |
artikel |
2 |
Adapting and piloting a vaccine hesitancy questionnaire in rural Guatemala
|
Williams, Joshua T.B. |
|
|
39 |
2 |
p. 180-184 |
artikel |
3 |
Adjustments for oral fluid quality and collection methods improve prediction of circulating tetanus antitoxin: Approaches for correcting antibody concentrations detected in a non-invasive specimen
|
Garrison-Desany, Henri |
|
|
39 |
2 |
p. 423-430 |
artikel |
4 |
A model for the incremental burden of invasive Haemophilus influenzae type b due to a decline of childhood vaccination during the COVID-19 outbreak: A dynamic transmission model in Japan
|
Kitano, Taito |
|
|
39 |
2 |
p. 343-349 |
artikel |
5 |
Assessing the impact of shared decision making processes on influenza vaccination rates in adult patients in outpatient care: A systematic review and meta-analysis
|
Sanftenberg, Linda |
|
|
39 |
2 |
p. 185-196 |
artikel |
6 |
A systematic review of factors that influence the acceptability of vaccines among Canadians
|
Gates, Allison |
|
|
39 |
2 |
p. 222-236 |
artikel |
7 |
Bivalent non-typhoidal Salmonella outer membrane vesicles immunized mice sera confer passive protection against gastroenteritis in a suckling mice model
|
Maiti, Suhrid |
|
|
39 |
2 |
p. 380-393 |
artikel |
8 |
Broad cross-national public support for accelerated COVID-19 vaccine trial designs
|
Broockman, David |
|
|
39 |
2 |
p. 309-316 |
artikel |
9 |
Consumer acceptability and validity of m-Health for the detection of adverse events following immunization – The Stimulated Telephone Assisted Rapid Safety Surveillance (STARSS) randomised control trial
|
Gold, M.S. |
|
|
39 |
2 |
p. 237-246 |
artikel |
10 |
Cost-effectiveness of live-attenuated influenza vaccination among school-age children
|
Wenzel, Natasha S. |
|
|
39 |
2 |
p. 447-456 |
artikel |
11 |
Editorial Board/Aims and Scope
|
|
|
|
39 |
2 |
p. IFC |
artikel |
12 |
Effects of rotavirus NSP4 protein on the immune response and protection of the SR69A-VP8* nanoparticle rotavirus vaccine
|
Liu, Cunbao |
|
|
39 |
2 |
p. 263-271 |
artikel |
13 |
Efficacy of m-Health for the detection of adverse events following immunization – The stimulated telephone assisted rapid safety surveillance (STARSS) randomised control trial
|
Gold, M.S. |
|
|
39 |
2 |
p. 332-342 |
artikel |
14 |
From bad to worse II: Risk amplification of the HPV vaccine on Facebook
|
Luisi, Monique L.R. |
|
|
39 |
2 |
p. 303-308 |
artikel |
15 |
HED: Trying to work our way back to normal
|
Davis, Jennifer |
|
|
39 |
2 |
p. 169-170 |
artikel |
16 |
How to ensure we can track and trace global use of COVID-19 vaccines?
|
Vander Stichele, Robert H. |
|
|
39 |
2 |
p. 176-179 |
artikel |
17 |
Impact and effectiveness of the 10-valent pneumococcal conjugate vaccine on invasive pneumococcal disease among children under 5 years of age in the Netherlands
|
Peckeu, L. |
|
|
39 |
2 |
p. 431-437 |
artikel |
18 |
In-depth analysis of pneumococcal serotypes in Belgian children (2015–2018): Diversity, invasive disease potential, and antimicrobial susceptibility in carriage and disease
|
Desmet, Stefanie |
|
|
39 |
2 |
p. 372-379 |
artikel |
19 |
Individual preferences for COVID-19 vaccination in China
|
Leng, Anli |
|
|
39 |
2 |
p. 247-254 |
artikel |
20 |
Lipophosphoglycan-3 protein from Leishmania infantum chagasi plus saponin adjuvant: A new promising vaccine against visceral leishmaniasis
|
de Oliveira Emerick, Sabrina |
|
|
39 |
2 |
p. 282-291 |
artikel |
21 |
Locked Down
|
Soreca, Vincent |
|
|
39 |
2 |
p. 167-168 |
artikel |
22 |
Long-lasting heterologous antibody responses after sequential vaccination with A/Indonesia/5/2005 and A/Vietnam/1203/2004 pre-pandemic influenza A(H5N1) virus vaccines
|
Haveri, Anu |
|
|
39 |
2 |
p. 402-411 |
artikel |
23 |
Meningococcal vaccination in patients with newly diagnosed asplenia in the United States
|
Ghaswalla, Parinaz K. |
|
|
39 |
2 |
p. 272-281 |
artikel |
24 |
Mobile phone reminders for enhancing uptake, completeness and timeliness of routine childhood immunization in low and middle income countries: A systematic review and meta-analysis
|
Yunusa, Umar |
|
|
39 |
2 |
p. 209-221 |
artikel |
25 |
National vaccine coverage trends and funding in Latin America and the Caribbean
|
Llau, Anthoni F |
|
|
39 |
2 |
p. 317-323 |
artikel |
26 |
New vaccine production platforms used in developing SARS-CoV-2 vaccine candidates
|
Ura, Takehiro |
|
|
39 |
2 |
p. 197-201 |
artikel |
27 |
Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists
|
Zacharia, Athina |
|
|
39 |
2 |
p. 292-302 |
artikel |
28 |
PIPDeploy: Development and implementation of a gamified table top simulation exercise to strengthen national pandemic vaccine preparedness and readiness
|
Ghiga, Ioana |
|
|
39 |
2 |
p. 364-371 |
artikel |
29 |
Preclinical evaluation of tuberculosis vaccine candidates: Is it time to harmonize study design and readouts for prioritizing their development?
|
Flores-Valdez, Mario Alberto |
|
|
39 |
2 |
p. 173-175 |
artikel |
30 |
Pregnant people deserve the protection offered by SARS-CoV-2 vaccines
|
Maykin, Melanie M. |
|
|
39 |
2 |
p. 171-172 |
artikel |
31 |
Priority allocation of pandemic influenza vaccines in Australia – Recommendations of 3 community juries
|
Degeling, C. |
|
|
39 |
2 |
p. 255-262 |
artikel |
32 |
Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France
|
Majed, Laureen |
|
|
39 |
2 |
p. 438-446 |
artikel |
33 |
Safety of maternal pertussis vaccination on pregnancy and birth outcomes: A prospective cohort study
|
Mohammed, Hassen |
|
|
39 |
2 |
p. 324-331 |
artikel |
34 |
Systematic review of Marburg virus vaccine nonhuman primate studies and human clinical trials
|
Dulin, Nicholas |
|
|
39 |
2 |
p. 202-208 |
artikel |
35 |
Trends in the uptake of pediatric measles-containing vaccine in the United States: A Disneyland effect?
|
Doll, Margaret K. |
|
|
39 |
2 |
p. 357-363 |
artikel |
36 |
Understanding the messages and motivation of vaccine hesitant or refusing social media influencers
|
Leader, Amy E. |
|
|
39 |
2 |
p. 350-356 |
artikel |
37 |
Vaccination with chimeric protein induces protection in murine model against ascariasis
|
de Castro, Joseane C. |
|
|
39 |
2 |
p. 394-401 |
artikel |